Collegium Pharmaceutical Inc
COLL
Market Cap$928.29M
Close$
$17.40
41.6% downside
Current Fair Value
41.6% downsideOvervalued by 41.6% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $928.29 Million |
|---|---|
| Enterprise Value | $1.13 Billion |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $2.14 |
| Beta | 0.63 |
| Outstanding Shares | 32,078,621 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | 13.39 |
|---|---|
| PEG | -24.46 |
| Price to Sales | 1.66 |
| Price to Book Ratio | 0.68 |
| Enterprise Value to Revenue | 1.88 |
| Enterprise Value to EBIT | 5.7 |
| Enterprise Value to Net Income | 12 |
| Total Debt to Enterprise | 0.24 |
| Debt to Equity | 0.16 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Collegium Pharmaceutical Inc
CEO: Joseph Ciaffoni